Billionaire Larry Robbins’ Long-Term Stock Picks

Page 10 of 15

6. McKesson Corporation (NYSE:MCK

Number of Hedge Fund Holders: 57

Glenview Capital’s Stake: $131.9 million

McKesson Corporation (NYSE:MCK) provides healthcare services. The following key aspects make this company a standout investment. To start with, as per the report for the fourth quarter of 2024, consolidated revenues of $76.4 billion increased by 11%, reflecting strong overall sales performance. Also, earnings per diluted share from continuing operations of $6.02 increased by $0.31, showing improved profitability and financial strength, which is positive for investors. Secondly, McKesson’s dedicated business unit, InspiroGene, partnered with Vertex Pharmaceuticals to expand distribution options for CASGEVY, the first CRISPR-based gene-editing therapy approved by the US Food and Drug Administration. This partnership demonstrates a commitment to advancing cell and gene therapies for patients living with debilitating diseases.

Page 10 of 15